208 related articles for article (PubMed ID: 24260412)
1. Response of Merkel cell polyomavirus-positive merkel cell carcinoma xenografts to a survivin inhibitor.
Dresang LR; Guastafierro A; Arora R; Normolle D; Chang Y; Moore PS
PLoS One; 2013; 8(11):e80543. PubMed ID: 24260412
[TBL] [Abstract][Full Text] [Related]
2. Survivin is a therapeutic target in Merkel cell carcinoma.
Arora R; Shuda M; Guastafierro A; Feng H; Toptan T; Tolstov Y; Normolle D; Vollmer LL; Vogt A; Dömling A; Brodsky JL; Chang Y; Moore PS
Sci Transl Med; 2012 May; 4(133):133ra56. PubMed ID: 22572880
[TBL] [Abstract][Full Text] [Related]
3. Dual inhibition of MDM2 and MDM4 in virus-positive Merkel cell carcinoma enhances the p53 response.
Park DE; Cheng J; Berrios C; Montero J; Cortés-Cros M; Ferretti S; Arora R; Tillgren ML; Gokhale PC; DeCaprio JA
Proc Natl Acad Sci U S A; 2019 Jan; 116(3):1027-1032. PubMed ID: 30598450
[TBL] [Abstract][Full Text] [Related]
4. Characterization of an early passage Merkel cell polyomavirus-positive Merkel cell carcinoma cell line, MS-1, and its growth in NOD scid gamma mice.
Guastafierro A; Feng H; Thant M; Kirkwood JM; Chang Y; Moore PS; Shuda M
J Virol Methods; 2013 Jan; 187(1):6-14. PubMed ID: 23085629
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA expression patterns related to merkel cell polyomavirus infection in human merkel cell carcinoma.
Xie H; Lee L; Caramuta S; Höög A; Browaldh N; Björnhagen V; Larsson C; Lui WO
J Invest Dermatol; 2014 Feb; 134(2):507-517. PubMed ID: 23962809
[TBL] [Abstract][Full Text] [Related]
6. High-affinity Rb binding, p53 inhibition, subcellular localization, and transformation by wild-type or tumor-derived shortened Merkel cell polyomavirus large T antigens.
Borchert S; Czech-Sioli M; Neumann F; Schmidt C; Wimmer P; Dobner T; Grundhoff A; Fischer N
J Virol; 2014 Mar; 88(6):3144-60. PubMed ID: 24371076
[TBL] [Abstract][Full Text] [Related]
7. Conversion of Sox2-dependent Merkel cell carcinoma to a differentiated neuron-like phenotype by T antigen inhibition.
Harold A; Amako Y; Hachisuka J; Bai Y; Li MY; Kubat L; Gravemeyer J; Franks J; Gibbs JR; Park HJ; Ezhkova E; Becker JC; Shuda M
Proc Natl Acad Sci U S A; 2019 Oct; 116(40):20104-20114. PubMed ID: 31527246
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of Merkel cell polyomavirus and risk of Merkel cell carcinoma.
Faust H; Andersson K; Ekström J; Hortlund M; Robsahm TE; Dillner J
Int J Cancer; 2014 Feb; 134(4):844-8. PubMed ID: 23922031
[TBL] [Abstract][Full Text] [Related]
9. The Merkel cell polyomavirus and its involvement in Merkel cell carcinoma.
Amber K; McLeod MP; Nouri K
Dermatol Surg; 2013 Feb; 39(2):232-8. PubMed ID: 23387356
[TBL] [Abstract][Full Text] [Related]
10. Merkel cell polyomavirus-positive Merkel cell carcinoma cells do not require expression of the viral small T antigen.
Angermeyer S; Hesbacher S; Becker JC; Schrama D; Houben R
J Invest Dermatol; 2013 Aug; 133(8):2059-64. PubMed ID: 23439392
[TBL] [Abstract][Full Text] [Related]
11. ALK and EGFR expression by immunohistochemistry are associated with Merkel cell polyomavirus status in Merkel cell carcinoma.
Veija T; Kero M; Koljonen V; Böhling T
Histopathology; 2019 May; 74(6):829-835. PubMed ID: 30588655
[TBL] [Abstract][Full Text] [Related]
12. Action of YM155 on clear cell renal cell carcinoma does not depend on survivin expression levels.
Sim MY; Huynh H; Go ML; Yuen JSP
PLoS One; 2017; 12(6):e0178168. PubMed ID: 28582447
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of YM155, a selective small-molecule survivin suppressant, alone and in combination with docetaxel in human malignant melanoma models.
Yamanaka K; Nakahara T; Yamauchi T; Kita A; Takeuchi M; Kiyonaga F; Kaneko N; Sasamata M
Clin Cancer Res; 2011 Aug; 17(16):5423-31. PubMed ID: 21737502
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of YM155, a selective survivin suppressant, in combination with cisplatin in hepatoblastoma.
Yu Y; Zhao X; Zhang Y; Kang Y; Wang J; Liu Y
Oncol Rep; 2015 Jul; 34(1):407-14. PubMed ID: 25955434
[TBL] [Abstract][Full Text] [Related]
15. The HSP70 modulator MAL3-101 inhibits Merkel cell carcinoma.
Adam C; Baeurle A; Brodsky JL; Wipf P; Schrama D; Becker JC; Houben R
PLoS One; 2014; 9(4):e92041. PubMed ID: 24694787
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous lung metastasis formation of human Merkel cell carcinoma cell lines transplanted into scid mice.
Knips J; Czech-Sioli M; Spohn M; Heiland M; Moll I; Grundhoff A; Schumacher U; Fischer N
Int J Cancer; 2017 Jul; 141(1):160-171. PubMed ID: 28380668
[TBL] [Abstract][Full Text] [Related]
17. Correlation of Merkel cell polyomavirus positivity with PDGFRα mutations and survivin expression in Merkel cell carcinoma.
Batinica M; Akgül B; Silling S; Mauch C; Zigrino P
J Dermatol Sci; 2015 Jul; 79(1):43-9. PubMed ID: 25936870
[TBL] [Abstract][Full Text] [Related]
18. Merkel Cell Polyomavirus Small Tumor Antigen Activates Matrix Metallopeptidase-9 Gene Expression for Cell Migration and Invasion.
Nwogu N; Ortiz LE; Whitehouse A; Kwun HJ
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669331
[TBL] [Abstract][Full Text] [Related]
19. MCV and Merkel cell carcinoma: a molecular success story.
Arora R; Chang Y; Moore PS
Curr Opin Virol; 2012 Aug; 2(4):489-98. PubMed ID: 22710026
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of p53 restriction in Merkel cell carcinoma cells are independent of the Merkel cell polyoma virus T antigens.
Houben R; Dreher C; Angermeyer S; Borst A; Utikal J; Haferkamp S; Peitsch WK; Schrama D; Hesbacher S
J Invest Dermatol; 2013 Oct; 133(10):2453-2460. PubMed ID: 23563200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
